Free Trial

Celularity (CELUW) Competitors

Celularity logo
$0.02 0.00 (0.00%)
(As of 12/17/2024 ET)

CELUW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Celularity stock or one of its competitors? The main competitors of Celularity include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Celularity vs.

Celularity (NASDAQ:CELUW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, community ranking, risk, analyst recommendations, media sentiment, earnings and profitability.

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Celularity's average media sentiment score of 1.87 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Celularity Very Positive
180 Life Sciences Very Positive

Celularity and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
CelularityN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$48.20MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Celularity beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELUW vs. The Competition

MetricCelularityBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$203.49M$5.14B$9.31B
Dividend YieldN/A3.54%4.81%4.06%
P/E RatioN/A317.19135.1917.53
Price / SalesN/A15,985.321,224.59140.21
Price / CashN/A11.7840.6537.95
Price / BookN/A7.284.884.92
Net IncomeN/A-$18.42M$118.97M$225.78M
7 Day PerformanceN/A187.68%15.53%-1.58%
1 Month PerformanceN/A134.37%15.54%6.67%
1 Year PerformanceN/A113.38%34.63%22.48%

Celularity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELUW
Celularity
N/A$0.02
flat
N/A+196.3%$0.00$48.20M0.00220Gap Up
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+41.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/A$0.04
-25.7%
N/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.16
+6.2%
N/A+4.1%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040Gap Up
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+12.9%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.7799 of 5 stars
$12.05
+2.1%
$18.00
+49.4%
+13.9%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.004Gap Up
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
-0.1%
N/A+263.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
flat
N/AN/A$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:CELUW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners